Learn more

NEUROSEARCH AS

Overview
  • Total Patents
    2,097
  • GoodIP Patent Rank
    235,594
About

NEUROSEARCH AS has a total of 2,097 patent applications. Its first patent ever was published in 1989. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ALCARAZ LILIAN, ASTRAZENECA AB PUBL and CHACKALAMANNIL SAMUEL.

Patent filings per year

Chart showing NEUROSEARCH ASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Peters Dan 918
#2 Olsen Gunnar M 567
#3 Nielsen Elsebet Oestergaard 433
#4 Nielsen Elsebet Ostergaard 334
#5 Christophersen Palle 255
#6 Teuber Lene 238
#7 Redrobe John Paul 226
#8 Timmermann Daniel B 218
#9 Ahring Philip K 209
#10 Moldt Peter 207

Latest patents

Publication Filing date Title
WO2012139925A1 Labelled and un-labelled methyl-pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
WO2012000881A1 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011117289A1 Chromen-2-one derivatives and their use as monoamine neuro-transmitter re-uptake inhibitors
US2013040985A1 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
ZA201100325B Treatment of anxiety disorders
WO2011073299A1 Pyridinyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators
EP2513087A1 Tetrazole derivatives as nicotinic acetylcholine receptor moudlators
WO2011073298A1 Tetrazole derivatives as nicotinic acetylcholine receptor modulators
WO2011073296A1 Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators
WO2011058002A1 Labelled pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their use in diagnostic methods
EP2475656A1 2, 3, 6 -triamino substituted pyridines as kv7 (kcnq) channel modulators
WO2011026891A1 Substituted pyridine derivatives and their medical use
CA2760981A1 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2010122064A1 Substituted naphthyridine derivatives and their medical use
WO2010112485A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
WO2010112486A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
WO2010112484A1 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
WO2010106106A1 2, 5-disubstituted tetrazole derivatives and their use as nicotinic acetylcholine receptor modulators
WO2010103064A1 Novel benzoxazinone derivatives useful for the treatment of cns disorders
EP2408747A1 Substituted pyridine derivatives and their medical use